Live Quote · NASDAQATAIHealthcare· Biotechnology

Atai Beckley Inc.

$5.19 6.35%(+$0.31)
TickerSpark Score
66/100
Solid
50
Valuation
40
Profitability
55
Growth
84
Health
100
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ATAI research report →

52-Week Range63% of range
Low
$2.53
Current
$5.19
High
$6.75
Company Overviewwww.ataibeckley.com

About the company

Atai Beckley Inc. operates as a clinical-stage biopharmaceutical firm dedicated to the discovery, advancement, and commercialization of innovative therapeutic solutions for a variety of mental health conditions. The company's operations extend across the United States, Germany, and Canada.

CEO
Christian Angermayer
IPO
2021
Employees
99
HQ
New York, NY, US

Price Chart

+88.73% · this period
$6.45$4.54$2.62Jul 02Dec 31Jul 02
Valuation
Market Cap
$1.91B
P/E
-1.77
P/S
547.82
P/B
5.92
EV/EBITDA
-2.82
Div Yield
0.00%
Profitability
Gross Margin
82.02%
Op Margin
-3658.03%
Net Margin
-19019.44%
ROE
-366.49%
ROIC
-53.11%
Growth & Income
Revenue
$4.09M · 1227.60%
Net Income
$-660,047,000 · -342.19%
EPS
$-2.91 · -212.90%
Op Income
$-99,761,000
FCF YoY
-25.50%
Performance & Tape
52W High
$6.75
52W Low
$2.53
50D MA
$4.31
200D MA
$4.29
Beta
1.57
Avg Volume
7.14M

Get TickerSpark's AI analysis on ATAI

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Nov 25, 25Feilding-Mellen Cosmoother10,000
Nov 25, 25Feilding-Mellen Cosmosell40,400
Nov 5, 25HERSHBERG ROBERTother456,011
Nov 5, 25HERSHBERG ROBERTother103,000
Nov 5, 25HERSHBERG ROBERTother97,716
Nov 5, 25HERSHBERG ROBERTother62,394
Nov 5, 25Feilding-Mellen Cosmoother7,702,990
Nov 5, 25Feilding-Mellen Cosmoother103,000
Nov 5, 25Feilding-Mellen Cosmoother40,400
Nov 4, 25Braunstein Scottother56,818
Coverage · ATAI

Our ATAI coverage

Recent articles, reports, and earnings notes.

View all →
For Active Investors

Want a deeper read on ATAI?

Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.

Generate ATAI report →
Internal Compare

Similar companies

Peers in the same neighborhood.